Can VR keep teens off vapes? yale tests a new approach
NCT ID NCT07362069
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a virtual reality (VR) program designed to help 8th graders avoid e-cigarettes and manage their emotions. Researchers at Yale University will first gather feedback from students and school staff to shape the program, then test whether it is easy to use and acceptable in real classrooms. The study involves 40 participants and focuses on whether the VR tool is practical, not yet on whether it actually reduces vaping.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
virtual reality intervention
What this could lead to
If it works, this could provide schools with an engaging VR tool to prevent e-cigarette use and teach emotion regulation to adolescents.
What could go wrong
This is a very small, early-phase study (40 participants) focused on feasibility and acceptability, not on proving the program actually prevents vaping. The results may not apply to all schools or students.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VAPING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Yale University
New Haven, Connecticut, 06520, United States